PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions is a paper indexed in ScholarIQ from OpenAlex.
How many citations does PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions have?
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions has 213 citations in the OpenAlex counts ScholarIQ stores.
When was PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions published?
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions has 2016 year in the ScholarIQ index.
What is the open-access status of PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions?
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions has hybrid oa status in the ScholarIQ index.
What is the DOI of PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions?
The DOI for PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions is on the source record.
What is the PMID of PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions?
The PMID for PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions is on the source record.
What is the OpenAlex record for PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions?
The OpenAlex for PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions is on the source record.